Open AccessDeveloping novel drugs for systemic lupus erythematosus. Lessons learned from the belimumab trials
Author(s) -
Cristina Pamfil,
Antonis Fanouriakis,
Dimitrios T. Boumpas
Publication year - 2012
Publication title -
reviews in health care
Language(s) - English
Resource type - Journals
eISSN - 2038-6702
pISSN - 2038-6699
DOI - 10.7175/rhc.20633209-222
Subject(s) - belimumab , medicine , b cell activating factor , immunology , monoclonal antibody , clinical trial , pathogenesis , systemic lupus erythematosus , disease , autoantibody , clinical endpoint , antibody , b cell
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom